Cognitive improvement of compound danshen in an Aβ25-35 peptide-induced rat model of Alzheimer’s disease

被引：0
|
作者：
Min Liu
Haibiao Guo
Chuyuan Li
Deqin Wang
Jingang Wu
Canmao Wang
Jiangping Xu
Ren-an Qin
机构：
[1] Modern Chinese Medicine Research Institute of Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine Co.,Department of Pharmacology, School of Pharmaceutical Sciences
[2] Ltd.,Post Doctoral Scientific Research Center
[3] Southern Medical University,undefined
[4] Guangzhou Pharmaceutical Corporation,undefined
来源：
BMC Complementary and Alternative Medicine | / 15卷
关键词：
Alzheimer’s disease; Compound danshen; Insulin-degrading enzyme (IDE); Neprilysin (NEP);
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Cognitive improvement of compound danshen in an Aβ25-35 peptide-induced rat model of Alzheimer's disease
    Liu, Min
    Guo, Haibiao
    Li, Chuyuan
    Wang, Deqin
    Wu, Jingang
    Wang, Canmao
    Xu, Jiangping
    Qin, Ren-an
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2015, 15
  • [2] Neuroprotective effects of salvianolic acid B on an Aβ25-35 peptide-induced mouse model of Alzheimer's disease
    Lee, Young Woo
    Kim, Dong Hyun
    Jeon, Su Jin
    Park, Se Jin
    Kim, Jong Min
    Jung, Jun Man
    Lee, Hyung Eun
    Bae, Shin Gil
    Oh, Hee Kyong
    Son, Kun Ho Ho
    Ryu, Jong Hoon
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 704 (1-3) : 70 - 77
  • [3] Effect of adrenalectomy on nucleus Meynert neurons in amyloid-β 25-35 peptide-induced model of Alzheimer's disease
    Simonyan, K.
    Mnatsakanyan, V.
    Stepanyan, H.
    Chavushyan, V.
    Meliksetyan, I.
    Avetisyan, Z.
    Mnatsakanyan, H.
    JOURNAL OF NEUROLOGY, 2010, 257 : S64 - S64
  • [4] Effects of cotinine and 6-hydroxy-L-nicotine on memory impairment in Aβ25-35 peptide-induced an Alzheimer's disease rat model
    Boiangiu, R. S.
    Mihasan, M.
    Hritcu, L.
    FEBS OPEN BIO, 2019, 9 : 232 - 233
  • [5] Gene Expression Profile of Hippocampus in Aβ (25-35) Induced Alzheimer's Disease Model Rat
    Huang, F. J.
    Tian, X. X.
    Li, W. P.
    Li, Y. H.
    Shen, J. G.
    Wu, Z. Z.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2016, 64 : S341 - S341
  • [6] Interaction of the Alzheimer Aβ(25-35) peptide segment with model membranes
    Cuco, Andreia
    Serro, Ana Paula
    Farinha, Jose Paulo
    Saramago, Benilde
    da Silva, Amelia Goncalves
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2016, 141 : 10 - 18
  • [7] Cognitive-enhancing activities of the polyprenol preparation Ropren® in gonadectomized β-amyloid (25-35) rat model of Alzheimer's disease
    Fedotova, Julia
    Soultanov, Vagif
    Nikitina, Tamara
    Roschin, Victor
    Ordyan, Natalia
    Hritcu, Lucian
    PHYSIOLOGY & BEHAVIOR, 2016, 157 : 55 - 62
  • [8] Neuroprotection by hypothalamic peptide proline-rich peptide-1 in Aβ25-35 model of Alzheimer's disease
    Galoyan, Armen A.
    Sarkissian, John S.
    Chavushyan, Vergineh A.
    Meliksetyan, Irina B.
    Avagyan, Zaruhi E.
    Poghosyan, Mikhail V.
    Vahradyan, Hasmik G.
    Mkrtchian, Hovhannes H.
    Abrahamyan, Davit O.
    ALZHEIMERS & DEMENTIA, 2008, 4 (05) : 332 - 344
  • [9] β-amyloid peptide (25-35) as a tool for in vivo modelling Alzheimer's disease in rats
    Stepanichev, MY
    Onufriev, MV
    Moiseeva, YV
    Lazareva, NA
    Alessenko, AV
    Victorov, IV
    Gulyaeva, NV
    JOURNAL OF NEUROCHEMISTRY, 2001, 77 : 19 - 19
  • [10] GSK-3β as a target for apigenin-induced neuroprotection against Aβ 25-35 in a rat model of Alzheimer's disease
    Alsadat, Alireza Moein
    Nikbakht, Farnaz
    Nia, Hadiseh Hossein
    Golab, Fereshteh
    Khadem, Yasaman
    Barati, Mahmoud
    Vazifekhah, Somayeh
    NEUROPEPTIDES, 2021, 90
12345